• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Valeant

Valeant

Page 3 of 12

Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health

T. Rowe Price Sues Valeant Over Alleged Fraud

By Sy Mukherjee
August 18, 2016
Here’s Why Shares of Valeant are Soaring
Finance

Here’s Why Shares of Valeant are Soaring

By Lucinda Shen
August 17, 2016
Berkshire Hathaway Inc. Annual General Meeting
Finance

How Valeant Defies the Warren Buffett School of Investing

By Jen Wieczner
August 11, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
Finance

Valeant Executives May Be Facing Criminal Prosecution

By Reuters
August 11, 2016
Squawk Box - Season 20
Finance

Bill Ackman Met Big Investors About Valeant at a Private Brainstorming Dinner

By Reuters
August 10, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
Finance

Valeant’s Troubles Aren’t Driving It To Lower Drug Prices

By Jen Wieczner
August 9, 2016
Valeant’s CEO Says He Is Not Actively Shopping Core Assets
Health

Valeant’s CEO Says He Is Not Actively Shopping Core Assets

By Reuters
August 9, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in  Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Health

Here’s Why Shares of Valeant Are Jumping

By Reuters
August 9, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in  Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Finance

Widely Loathed Valeant Pharmaceuticals Gets New Top Lawyer and PR Exec

By Reuters
August 8, 2016
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
Health

Whistleblower Claims Celgene Colluded With Charities to Drive Profits

By Sy Mukherjee
August 1, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
Health

The FDA Sees a Problem with Valeant’s New Glaucoma Eye Drops

By Reuters
July 22, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Investors Pull $600M After Ackman’s Bad Bets

By Michelle Celarier
July 19, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Former Valeant CEO Michael Pearson Just Sold About Five Million Shares of the Company

By Lucinda Shen
July 13, 2016
PETA protesters against the use of meat blocked Re
Finance

Valeant’s Second Largest Investor Just Dumped the Rest of Its Stock

By Lucinda Shen
July 13, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in  Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Health

New Valeant CEO Meets Investors Amid Company Struggles

By Reuters
June 14, 2016

Most Popular

  • Success
    Millionaire Alexis Ohanian walked out of the LSAT 20 minutes in, went to a Waffle House, and decided he was ‘gonna...
    By Preston Fore
  • Success
    Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
    By Emma Burleigh
  • Politics
    Meet all 33 Silicon Valley power players at Trump’s high-profile tech dinner—and here’s Elon Musk’s explanation for why...
    By Dave Smith
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.